| 发明名称 |
CCR2 ANTAGONISTS FOR TREATMENT OF FIBROSIS |
| 摘要 |
Anti-MCP-1/CCR2 antagonist therapy is provided for the control or reversal of fibrosis related diseases, including, e.g., but not limited to MCP-1/CCR2 antagonist therapy for the modulation of profibrotic markers associated with fibrotic processses including collagen matrix deposition and alveolar collapse. |
| 申请公布号 |
WO2008060783(A3) |
申请公布日期 |
2008.10.23 |
| 申请号 |
WO2007US80542 |
申请日期 |
2007.10.05 |
| 申请人 |
CENTOCOR;DAS, ANUK;MURRAY, LYNN;SYED, FAHRAT |
发明人 |
DAS, ANUK;MURRAY, LYNN;SYED, FAHRAT |
| 分类号 |
A61K39/395;A61P11/00;A61P17/02;G01N33/50 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
